A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Clinical trial NCT00635817 · COMPLETED

Trial details

NCT number: NCT00635817
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Puberty, Precocious

Start date: 2008-06-01
Primary completion: 2010-01-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.